Published in J Natl Cancer Inst on August 21, 2002
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev (2003) 2.90
Etiologic heterogeneity among non-Hodgkin lymphoma subtypes. Blood (2008) 2.49
Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States. J Clin Oncol (2015) 2.40
Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial. J Infect Dis (2008) 2.31
Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res (2009) 2.03
Declining death rates reflect progress against cancer. PLoS One (2010) 1.91
Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett (2009) 1.54
HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. Clin Infect Dis (2008) 1.42
Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges. AIDS (2014) 1.41
Persistent Kaposi sarcoma in the era of highly active antiretroviral therapy: characterizing the predictors of clinical response. AIDS (2008) 1.33
The epidemic of non-Hodgkin lymphoma in the United States: disentangling the effect of HIV, 1992-2009. Cancer Epidemiol Biomarkers Prev (2013) 1.27
Frequent and asymptomatic oropharyngeal shedding of human herpesvirus 8 among immunocompetent men. J Infect Dis (2006) 1.27
Personal use of hair dye and the risk of certain subtypes of non-Hodgkin lymphoma. Am J Epidemiol (2008) 1.23
Diffuse large B-cell lymphoma. Hematol Oncol Clin North Am (2008) 1.21
Contribution of HIV infection to mortality among cancer patients in Uganda. AIDS (2013) 1.19
Sporadic childhood Burkitt lymphoma incidence in the United States during 1992-2005. Pediatr Blood Cancer (2009) 1.16
HIV and cancer in Africa: mutual collaboration between HIV and cancer programs may provide timely research and public health data. Infect Agent Cancer (2011) 1.16
Occupational exposure to solvents and risk of non-Hodgkin lymphoma in Connecticut women. Am J Epidemiol (2008) 1.14
Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. Curr Opin Infect Dis (2011) 1.09
Non-Hodgkin lymphoma and occupational exposure to agricultural pesticide chemical groups and active ingredients: a systematic review and meta-analysis. Int J Environ Res Public Health (2014) 1.08
New approaches to the treatment of human herpesvirus 8-associated disease. Rev Med Virol (2008) 1.07
Epidemiology of Hodgkin's disease and non-Hodgkin's lymphoma. Eur J Nucl Med Mol Imaging (2003) 1.06
Study of non-Hodgkin's lymphoma mortality associated with industrial pollution in Spain, using Poisson models. BMC Public Health (2009) 1.04
Plasma organochlorine levels and risk of non-Hodgkin lymphoma in a cohort of men. Epidemiology (2010) 0.99
Liposomal daunorubicin as treatment for Kaposi's sarcoma. Int J Nanomedicine (2007) 0.97
Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection. AIDS (2013) 0.95
Risk Factors of Non-Hodgkin Lymphoma. Expert Opin Med Diagn (2011) 0.94
A Population-Level Evaluation of the Effect of Antiretroviral Therapy on Cancer Incidence in Kyadondo County, Uganda, 1999-2008. J Acquir Immune Defic Syndr (2015) 0.90
Detection of Kaposi's sarcoma associated herpesvirus nucleic acids using a smartphone accessory. Lab Chip (2014) 0.90
Optimization of immunotherapy in elderly cancer patients. Crit Rev Oncog (2013) 0.90
Epidemiology, Diagnosis, and Treatment of HIV-Associated Non-Hodgkin Lymphoma in Resource-Limited Settings. Adv Hematol (2012) 0.86
NF-κB as a target for oncogenic viruses. Curr Top Microbiol Immunol (2011) 0.86
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy. AIDS (2013) 0.86
Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends. Cancer Epidemiol Biomarkers Prev (2015) 0.86
Analysis of matched geographical areas to study potential links between environmental exposure to oil refineries and non-Hodgkin lymphoma mortality in Spain. Int J Health Geogr (2012) 0.86
Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus. Mol Cancer Ther (2007) 0.86
Multiplexed colorimetric detection of Kaposi's sarcoma associated herpesvirus and Bartonella DNA using gold and silver nanoparticles. Nanoscale (2013) 0.85
Genetic variation in N-acetyltransferases 1 and 2, cigarette smoking, and risk of non-Hodgkin lymphoma. Cancer Causes Control (2009) 0.85
Anal Cancer Screening: Barriers and Facilitators Among Ethnically Diverse Gay, Bisexual, Transgender, and Other Men Who Have Sex With Men. J Gay Lesbian Soc Serv (2008) 0.84
Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma. Blood (2007) 0.83
Clinical development of phosphatidylinositol 3-kinase inhibitors for non-Hodgkin lymphoma. Biomark Res (2013) 0.81
Treatment with valacyclovir, famciclovir, or antiretrovirals reduces human herpesvirus-8 replication in HIV-1 seropositive men. J Med Virol (2011) 0.80
Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial. Leuk Lymphoma (2016) 0.80
SHMT1 C1420T polymorphism contributes to the risk of non-Hodgkin lymphoma: evidence from 7309 patients. Chin J Cancer (2015) 0.79
Sarcomas other than Kaposi sarcoma occurring in immunodeficiency: interpretations from a systematic literature review. Curr Opin Oncol (2012) 0.79
Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin's lymphoma. Expert Rev Ophthalmol (2011) 0.78
Recreational drug use and risk of Kaposi's sarcoma in HIV- and HHV-8-coinfected homosexual men. AIDS Res Hum Retroviruses (2009) 0.78
Reduced human herpesvirus-8 oropharyngeal shedding associated with protease inhibitor-based antiretroviral therapy. J Clin Virol (2014) 0.78
Prognosis and delay of diagnosis among Kaposi's sarcoma patients in Uganda: a cross-sectional study. Infect Agent Cancer (2014) 0.77
AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy. Ethn Dis (2008) 0.77
Plasmablastic lymphoma in a previously undiagnosed AIDS patient: a case report. Head Neck Pathol (2008) 0.75
An Update on Kaposi's Sarcoma: Epidemiology, Pathogenesis and Treatment. Dermatol Ther (Heidelb) (2016) 0.75
Antibiotic use and risk of non-Hodgkin's lymphoma: a population-based case-control study. Br J Cancer (2007) 0.75
Racial and Ethnic Disparities in the Incidence and Trends of Soft Tissue Sarcoma Among Adolescents and Young Adults in the United States, 1995-2008. J Adolesc Young Adult Oncol (2013) 0.75
Structure of the opening reading frame 49 protein encoded by Kaposi's sarcoma associated herpesvirus (KSHV). J Virol (2016) 0.75
HIV-1 Evolutionary Patterns Associated with Metastatic Kaposi's Sarcoma during AIDS. Sarcoma (2016) 0.75
Disparities in Kaposi sarcoma incidence and survival in the United States: 2000-2013. PLoS One (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood (2005) 8.37
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev (2009) 8.08
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
Breast cancer statistics, 2013. CA Cancer J Clin (2013) 7.35
Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13
Breast cancer statistics, 2011. CA Cancer J Clin (2011) 6.12
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin (2007) 5.31
Epidemiology and risk factors for kidney cancer. Nat Rev Urol (2010) 5.25
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Merkel cell carcinoma and HIV infection. Lancet (2002) 4.72
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature (2012) 4.33
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst (2005) 4.14
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am (2002) 3.69
Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin (2014) 3.59
Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin (2012) 3.58
Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst (2009) 3.58
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood (2011) 3.30
Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol (2008) 3.21
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol (2005) 3.01
Racial disparity in renal cell carcinoma patient survival according to demographic and clinical characteristics. Cancer (2012) 2.95
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978-2001: An analysis of 26,758 cases. Int J Cancer (2006) 2.73
Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst (2006) 2.66
Probabilities of death from breast cancer and other causes among female breast cancer patients. J Natl Cancer Inst (2004) 2.60
Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol (2011) 2.58
Distinct breast cancer incidence and prognostic patterns in the NCI's SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat (2005) 2.57
Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev (2009) 2.50
Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid (2010) 2.48
US lung cancer trends by histologic type. Cancer (2014) 2.46
Trends in the incidence of testicular germ cell tumors in the United States. Cancer (2003) 2.45
Cancer statistics for African Americans. CA Cancer J Clin (2002) 2.45
Cancer statistics for African Americans, 2013. CA Cancer J Clin (2013) 2.44
Human herpesvirus 8 infection within families in rural Tanzania. J Infect Dis (2003) 2.42
International trends in liver cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2011) 2.40
Contemporary epidemiology of renal cell cancer. Cancer J (2008) 2.40
Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39
Elevated risk of lung cancer among people with AIDS. AIDS (2007) 2.20
Trends in breast cancer by race and ethnicity. CA Cancer J Clin (2004) 2.19
Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19
Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood (2009) 2.16
Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood (2010) 2.12
AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? Blood (2010) 2.10
International trends in the incidence of testicular cancer, 1973-2002. Cancer Epidemiol Biomarkers Prev (2010) 2.07
Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev (2011) 2.06
Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med (2004) 2.00
Tobacco control in the United States--recent progress and opportunities. CA Cancer J Clin (2009) 1.97
Immune deficiency and risk for malignancy among persons with AIDS. J Acquir Immune Defic Syndr (2003) 1.96
A geographic analysis of prostate cancer mortality in the United States, 1970-89. Int J Cancer (2002) 1.94
The influence of sex, race/ethnicity, and educational attainment on human immunodeficiency virus death rates among adults, 1993-2007. Arch Intern Med (2012) 1.92
Cancer statistics for Hispanics, 2003. CA Cancer J Clin (2003) 1.88
Recent trends in Black-White disparities in cancer mortality. Cancer Epidemiol Biomarkers Prev (2008) 1.86
Pancreatic cancer death rates by race among US men and women, 1970-2009. J Natl Cancer Inst (2013) 1.85
Lung cancer rates convergence in young men and women in the United States: analysis by birth cohort and histologic type. Int J Cancer (2003) 1.85
Incidence of noncutaneous melanomas in the U.S. Cancer (2005) 1.85
Rising prostate cancer rates in South Korea. Prostate (2006) 1.83
Hepatocellular carcinoma and other liver disease among Greenlanders chronically infected with hepatitis B virus: a population-based study. J Natl Cancer Inst (2011) 1.80
How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control (2006) 1.80
Gender is an age-specific effect modifier for papillary cancers of the thyroid gland. Cancer Epidemiol Biomarkers Prev (2009) 1.78
Cutaneous soft tissue sarcoma incidence patterns in the U.S. : an analysis of 12,114 cases. Cancer (2008) 1.74
Trends in the incidence of ocular melanoma in the United States, 1974-1998. Cancer Causes Control (2003) 1.72
Provirus load in breast milk and risk of mother-to-child transmission of human T lymphotropic virus type I. J Infect Dis (2004) 1.69
Sex disparities in cancer mortality and survival. Cancer Epidemiol Biomarkers Prev (2011) 1.68
Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat (2004) 1.67
Brain cancer incidence trends in relation to cellular telephone use in the United States. Neuro Oncol (2010) 1.63
Child survival in relation to mother's HIV infection and survival: evidence from a Ugandan cohort study. AIDS (2003) 1.62
Breast cancer trends among black and white women in the United States. J Clin Oncol (2005) 1.60
International patterns and trends in testis cancer incidence. Int J Cancer (2005) 1.60
Analysis of racial differences in incidence, survival, and mortality for malignant tumors of the uterine corpus. Cancer (2003) 1.57